During the past decade, Hospital Erasto Gaertner conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 17 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 11 clinical trials were completed. i.e. 52.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Erasto Gaertner" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Pfizer" with 4 trials sponsored, "Takeda" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Erasto Gaertner" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Erasto Gaertner" are "Prostate Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Breast Cancer" (2 trials), "Cancer of the Prostate" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Hospital Erasto Gaertner" in a lesser frequency.

Most popular intervention types in "Hospital Erasto Gaertner" are "Drug" (49 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Enzalutamide" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Erasto Gaertner" are 42 trials for "All" genders, 8 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Erasto Gaertner". undefined are not yet recruiting, 18 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hospital Erasto Gaertner, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Erasto Gaertner, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Hospital Erasto Gaertner has several departments that took part in Clinical trials: "Liga Paranaense de Combate ao Cancer" - 4 trials